Company profile: IVX Health
1.1 - Company Overview
Company description
- Provider of infusion and injection therapy for patients with complex chronic conditions, with community-based centers offering flexible scheduling and private suites. Treatments include IV therapies and injections for rheumatoid arthritis, Crohn's disease, multiple sclerosis, paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, Pompe disease, and thyroid cancer (Thyrogen, Truxima, Tysabri, Ultomiris, Lumizyme).
Products and services
- IV Infusion Therapy: IVX Health delivers infusion care for complex chronic conditions in private suites (private-suite), with flexible scheduling and centers located near patients for convenient access to treatment
- Tysabri Infusion Therapy: Tysabri treats adults with relapsing multiple sclerosis and moderately to severely active Crohn’s disease via IV infusion (IV-administered), delivered in IVX Health centers with flexible scheduling
- Truxima Infusion Therapy: Truxima, a biosimilar to Rituxan (biosimilar-class), treats moderately to severely active rheumatoid arthritis in adults and is administered via IV infusion in private suites at IVX Health
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to IVX Health
Urgent Care Group
HQ: United States
Website
- Description: Provider of urgent care services through combined and developed centers in partnership with providers and health systems, offering immediate treatment for illnesses and minor injuries, COVID-19 testing (rapid, RT-PCR, antibody), digital X-ray, on-site lab testing, veteran care via VA Community Care Program, and affordable self-pay options.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Urgent Care Group company profile →
Faceland
HQ: Germany
Website
- Description: Provider of injectable treatments and cosmetic surgery.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Faceland company profile →
Tend
HQ: United States
Website
- Description: Provider of technology-driven dental services focused on hassle-free, personalized, and straightforward care. Launched in October 2019, Tend builds dentistry around the patient, leveraging technology, a hospitality-driven mindset, and a top-tier clinical team, with 25 locations across New York, Washington DC, and Boston.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Tend company profile →
Sanderling Renal Services
HQ: United States
Website
- Description: Provider of dialysis and nephrology services to rural communities and home dialysis patients across the USA, offering 24/7 telemedicine coverage for hospitals and ERs via nephrologists, cardiologists, and internists; dialysis care in-center, at home, and in nursing homes; and a virtual specialist model with hospital privileges, EMR order entry/charting, and site visits to ensure care continuity.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sanderling Renal Services company profile →
Vocare
HQ: United Kingdom
Website
- Description: Provider of outsourced urgent care services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Vocare company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for IVX Health
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to IVX Health
2.2 - Growth funds investing in similar companies to IVX Health
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for IVX Health
4.2 - Public trading comparable groups for IVX Health
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →